Some patients experience mild electrolyte shifts during the first few days as their kidneys adjust to changes in sodium and water handling
UCSF neuroscientist Khaled Moussawi is now leading clinical work on GLP-1 drugs designed to target craving circuits, with potential applications across alcohol and opioid use disorder
Combined with potential GI side effects, this may lead to fluid and electrolyte loss, making intentional hydration more important
These GLP-1 patches cant work because: The ingredients are ineffective
Then, protein content of GLP-1R, PKA, PC1/3, PC2 and Pdx1 in four groups of cells was detected using Western blot (Figure 5B)
Additionally, there were more deaths in the Tirzepatide group than semaglutide (12 vs 1)